ISOREA AB received investment from Linnéa Capital AB

ISOREA AB is very happy to announce that we have received an investment from Linnéa Capital AB. This investment will help ISOREA AB to start its IVDR application procedure of the KIT designed to detect Early Alzheimer's by a sensitive and affordable blood test. 

Our KIT has the potential to detect Alzheimer's disease at Early stage or Mild Cognitive Impairment (MCI) stage and thereby helping patients to start medical interventions using new age drugs developed by other providers for patients at MCI stage. This KIT is also vital for blood screening at the Blood Banks before transfusion to the recipients, as a preventative measure from receiving isoaspartate containing bad albumin.

ISOREA AB is now part of UIC Accelerator

We are glad to announce that ISOREA AB has been selected in the prestigious Uppsala Innovation Centre (UIC) Accelerator Program. This is one of the top 5 accelerator programs in the world. We are very happy to be a part of it and getting connected with its vast investor and professional network. Apart from receiving financial support from UIC, we will also receive various advice through their great mentorship program.

We look forward to our journey together!

Pic. Mrs. Helena Kristersson (Program Director UIC Accelerator; centre) and Mr. Vinh Hoang (UIC associate; right) visiting the laboratory of Professor Roman Zubarev (Chairperson & CSO, ISOREA AB) at Karolinska Institutet. They are received by Dr. Sourav Pr. Mukherjee (CEO ISOREA AB; left).